Literature DB >> 25205557

Review: Cell Dynamics in Malignant Pleural Effusions.

Enrico Giarnieri1, Gianfranco Bellipanni2, Marcella Macaluso2, Rita Mancini1, Adam Carl Holstein2, Carla Milanese2, Maria Rosaria Giovagnoli1, Antonio Giordano2,3,4, Giuseppe Russo2.   

Abstract

Malignant pleural effusions (MPEs) are a common manifestation found in patients with lung cancer. After cytological and histological confirmation of malignancy, talc pleurodesis still remains the treatment of choice in patients with MPEs resistant to chemotherapy. Despite this, primary challenges include reduced quality of life and life expectancy in general. Therefore, a better understanding of the cell biology of MPEs, along with improvements in treatment is greatly needed. It has recently been demonstrated that MPEs may represent an excellent source for identification of molecular mechanisms within the tumor and its environment. The present review summarizes the current understanding of MPEs cells and tumor microenvironment, and particularly focuses on dissecting the cross-talk between MPEs and epithelial to mesenchymal transition (EMT), inflammation and cancer stem cells.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25205557     DOI: 10.1002/jcp.24806

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma.

Authors:  Hong-Liang Shen; Qing-Jun Liu; Pei-Qian Yang; Ye Tian
Journal:  Tumour Biol       Date:  2014-12-21

2.  Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway.

Authors:  Tao Yin; Guoping Wang; Sisi He; Guobo Shen; Chao Su; Yan Zhang; Xiawei Wei; Tinghong Ye; Ling Li; Shengyong Yang; Dan Li; Fuchun Guo; Zeming Mo; Yang Wan; Ping Ai; Xiaojuan Zhou; Yantong Liu; Yongsheng Wang; Yuquan Wei
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

3.  Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.

Authors:  Verena Tiran; Stefanie Stanzer; Ellen Heitzer; Michael Meilinger; Christopher Rossmann; Sigurd Lax; Oleksiy Tsybrovskyy; Nadia Dandachi; Marija Balic
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

4.  CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.

Authors:  Sara Bruschini; Simona di Martino; Maria Elena Pisanu; Luigi Fattore; Claudia De Vitis; Valentina Laquintana; Simonetta Buglioni; Eugenio Tabbì; Andrea Cerri; Paolo Visca; Gabriele Alessandrini; Francesco Facciolo; Christian Napoli; Marcella Trombetta; Antonio Santoro; Anna Crescenzi; Gennaro Ciliberto; Rita Mancini
Journal:  J Cell Physiol       Date:  2019-08-09       Impact factor: 6.384

5.  TGF-β Induced CTGF Expression in Human Lung Epithelial Cells through ERK, ADAM17, RSK1, and C/EBPβ Pathways.

Authors:  Shu-Ching Ou; Kuan-Jen Bai; Wun-Hao Cheng; Jing-Yun Chen; Chien-Huang Lin; Heng-Ching Wen; Bing-Chang Chen
Journal:  Int J Mol Sci       Date:  2020-11-29       Impact factor: 5.923

6.  Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization.

Authors:  Annalisa Bosi; Silvia Zanellato; Barbara Bassani; Adriana Albini; Alessandra Musco; Maria Cattoni; Matteo Desio; Elisa Nardecchia; Davide Giuseppe D'Urso; Andrea Imperatori; Lorenzo Dominioni; Douglas M Noonan; Lorenzo Mortara; Antonino Bruno
Journal:  J Immunol Res       Date:  2018-03-29       Impact factor: 4.818

7.  Detachment Activated CyPA/CD147 Induces Cancer Stem Cell Potential in Non-stem Breast Cancer Cells.

Authors:  Yao Meng; Xin-Yu Fan; Li-Jun Yang; Bao-Qing Xu; Duo He; Zhe Xu; Dong Wu; Bin Wang; Hong-Yong Cui; Shi-Jie Wang; Li-Juan Wang; Xiao-Qing Wu; Jian-Li Jiang; Liang Xu; Zhi-Nan Chen; Ling Li
Journal:  Front Cell Dev Biol       Date:  2020-10-16

8.  PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma.

Authors:  Wenqian Zhang; Tong Li; Bin Hu; Hui Li
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

9.  The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.

Authors:  Ming-Fang Wu; Chih-An Lin; Tzu-Hang Yuan; Hsiang-Yuan Yeh; Sheng-Fang Su; Chin-Lin Guo; Gee-Chen Chang; Ker-Chau Li; Chao-Chi Ho; Huei-Wen Chen
Journal:  Cancer Immunol Immunother       Date:  2020-11-11       Impact factor: 6.968

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.